Weizman Pharmaceuticals Private Limited
About Weizman Pharmaceuticals Private Limited
Data last updated:
Weizman Pharmaceuticals Private Limited is a private limited company based in Bahraich, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 18 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2018PTC111424. Its GSTIN is 09AACCW3366Q1ZK (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sadqa Farheen and Zameer Ahmad.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Zameer Ahmad Chandpura Near Tiprah Kothi, Bahraich, Uttar Pradesh, India – 271801.
As per the financials filed for FY 2025, the company reported a revenue of ₹49.87 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.89 Lakh (net margin 3.8%) and EBITDA of ₹3.01 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 9% over five years.
Company details
Contact details
Weizman Pharmaceuticals Private Limited's registered office is in Bahraich, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Zameer Ahmad Chandpura Near Tiprah Kothi, Bahraich, Uttar Pradesh, India – 271801
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Weizman Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Weizman Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Weizman Pharmaceuticals Private Limited, buy the company report.
Financials of Weizman Pharmaceuticals Private Limited
FY 2025 filings availableWeizman Pharmaceuticals Private Limited reported revenue of ₹49.87 Lakh (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 5% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Weizman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Weizman Pharmaceuticals Private Limited
Weizman Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sadqa Farheen | Director | 18 Dec 2018 | 7 Years 10 Months | Current |
| Zameer Ahmad | Director | 18 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Weizman Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lorica Pharmaceuticals Limited | ₹50.09 Lakh (FY 2025) | -13.0% | Badaun, Uttar Pradesh, India | |||
| Weizman Pharmaceuticals Private Limitedthis company | ₹49.87 Lakh (FY 2025) | ₹1.89 Lakh | 3.8% | 5.0% | Bahraich, Uttar Pradesh, India | |
| Curenetic Pharmaceuticals Private Limited | ₹49.82 Lakh (FY 2025) | 8.0% | Noida, Uttar Pradesh, India | |||
| Xenomics Pharmaceuticals Private Limited | ₹49.71 Lakh (FY 2024) | 53.0% | Hyderabad, Telangana, India | |||
| Vancorp Pharmaceuticals Private Limited | ₹49.64 Lakh (FY 2025) | 3.0% | Gautam Budh Nagar, Uttar Pradesh, India | |||
| Reinheit Pharmaceuticals Private Limited | ₹49.48 Lakh (FY 2024) | 132.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Weizman Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Weizman Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Weizman Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Weizman Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCW3366Q1ZK | Uttar Pradesh | Active | 10 Apr 2019 |
To see the full GST registrations and return filing status of Weizman Pharmaceuticals Private Limited, buy the company report.
Recent activity
Weizman Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Sadqa Farheen was appointed as Director on 18 Dec 2018.
Frequently asked questions
Weizman Pharmaceuticals is an active private limited company based in Bahraich, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 18 December 2018 (8+ years old) and is registered under CIN U51909UP2018PTC111424.
Weizman Pharmaceuticals has 2 current directors:
- Sadqa Farheen - Director
- Zameer Ahmad - Director
The latest financial statements of Weizman Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Weizman Pharmaceuticals is 09AACCW3366Q1ZK, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Weizman Pharmaceuticals is U51909UP2018PTC111424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Weizman Pharmaceuticals was incorporated on 18 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Weizman Pharmaceuticals by revenue are Lorica Pharmaceuticals Limited, Curenetic Pharmaceuticals Private Limited, Xenomics Pharmaceuticals Private Limited, Vancorp Pharmaceuticals Private Limited, Reinheit Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sadqa Farheen was appointed as Director on 18 Dec 2018. Zameer Ahmad was appointed as Director on 18 Dec 2018.
The registered office of Weizman Pharmaceuticals is at CO Zameer Ahmad Chandpura Near Tiprah Kothi, Bahraich, Uttar Pradesh, India – 271801.
Weizman Pharmaceuticals operates in the trading industry, in the specialty segment.
Weizman Pharmaceuticals can be reached at its registered office: CO Zameer Ahmad Chandpura Near Tiprah Kothi, Bahraich, Uttar Pradesh, India – 271801.